• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Nord Kapital makes first exit from Nord II with Hepro sale
Nord Kapital makes first exit from Nord II with Hepro sale

Swedish trade buyer AddLife acquires the Norwegian GP's portfolio company around two years after Nord's buyout

  • Exits
  • 24 February 2017
PE-backed Rad-x bolts on Acura
PE-backed Rad-x bolts on Acura

Deal marks the second bolt-on for the business, following the acquisition of Swiss diagnostic imaging provider IRD

  • Portfolio management
  • 23 February 2017
BioMedPartners hits CHF 75m first close for third fund
BioMedPartners hits CHF 75m first close for third fund

Healthcare-focused GP expects to reach a final close by early 2018

  • Funds
  • 23 February 2017
KDev et al. invest SEK 32m in Modus
KDev et al. invest SEK 32m in Modus

Developer of sickle cell disease treatments recently rebranded from Dilaforette and announced intention to float

  • Early-stage
  • 20 February 2017
CBPE's OH Assist acquires Working On Wellbeing
CBPE's OH Assist acquires Working On Wellbeing

Acquisition of mobile healthcare provider comes 14 months after the GP acquired OH Assist from Atos IT Services

  • Portfolio management
  • 16 February 2017
Karolinska exits Inhalation Sciences
Karolinska exits Inhalation Sciences

Family-owned investment company RУЅsunda FУЖrvaltning enters the company's capital structure as part of the deal

  • Exits
  • 14 February 2017
Forbion, Seroba co-lead €29m series-B for Prexton
Forbion, Seroba co-lead €29m series-B for Prexton

Backers include existing investors Merck Ventures, Ysios Capital and Sunstone Capital

  • Early-stage
  • 09 February 2017
Mid Europa sells Alpha Medical to Apax's Unilabs
Mid Europa sells Alpha Medical to Apax's Unilabs

Vendor has owned Slovakia-based Alpha Medical since a 2012 SBO, while Apax acquired Unilabs in December 2016

  • Exits
  • 09 February 2017
Inflexion invests in Medivet
Inflexion invests in Medivet

Deal is the latest in a number of private equity investments in the veterinary sector

  • UK / Ireland
  • 06 February 2017
Dunedin sells Steeper's BeBionic to Ottobock
Dunedin sells Steeper's BeBionic to Ottobock

Sale of the prosthetics company's division is the final exit for the GP's 2000-vintage debut fund

  • Exits
  • 03 February 2017
Phoenix invests in Rayner
Phoenix invests in Rayner

Deal for opthalmic implant business marks the second investment from Phoenix's 2016-vintage fourth vehicle

  • Buyouts
  • 31 January 2017
MBO Partenaires acquires Icare from Naxicap
MBO Partenaires acquires Icare from Naxicap

Naxicap Partners and Sofimac Partners entered the group as minority shareholders in 2012

  • Expansion
  • 26 January 2017
BPI, Sofinnova, Novo Nordisk-backed Lysogene launches IPO
BPI, Sofinnova, Novo Nordisk-backed Lysogene launches IPO

Sofinnova entered the group in 2014, leading a €16.5m round for the group

  • Exits
  • 26 January 2017
Industrifonden et al. in €9m round for Amra
Industrifonden et al. in €9m round for Amra

Funding round is Industrifondenт€™s third investment in Advanced MR Analytics

  • Nordics
  • 23 January 2017
PAI exits Cerba Healthcare in sale to Partners Group
PAI exits Cerba Healthcare in sale to Partners Group

PAI is exiting the group after a six-year holding, during which Cerba's turnover tripled

  • Exits
  • 23 January 2017
PAI-backed Ethypharm acquires Martindale Pharma
PAI-backed Ethypharm acquires Martindale Pharma

New combined entity will generate revenues in excess of т‚Ќ300m

  • France
  • 19 January 2017
IK sells dental group Colosseum Smile to Jacobs Holding
IK sells dental group Colosseum Smile to Jacobs Holding

GP exits Norway-headquartered dental group after a six-year holding

  • Exits
  • 13 January 2017
EMBL, Life Sciences Partners lead €8m series-A for Luxendo
EMBL, Life Sciences Partners lead €8m series-A for Luxendo

GPs completed the funding round launched in 2015 with an additional €2m injection

  • Early-stage
  • 12 January 2017
Boehringer Ingelheim leads €9m series-A for Heparegenix
Boehringer Ingelheim leads €9m series-A for Heparegenix

Backers to the funding round include Novo Seeds and High-Tech Gründerfonds

  • Early-stage
  • 12 January 2017
Caixa, Kereon lead €2.5m round for Transplant Biomedicals
Caixa, Kereon lead €2.5m round for Transplant Biomedicals

Deal marks the second round led by the two investors for the Spanish business

  • Early-stage
  • 12 January 2017
Magnum Capital reaps €135m in Generis sale
Magnum Capital reaps €135m in Generis sale

GP fully exits the business after eight-year holding period

  • Exits
  • 09 January 2017
Forbion, Fountain et al. in £23m series-B for Nerre Therapeutics
Forbion, Fountain et al. in £23m series-B for Nerre Therapeutics

Round also saw participation from existing investors Advent Life Sciences and Novo

  • Healthcare
  • 05 January 2017
Ardian's Dedalus raises €72m bond from Tikehau
Ardian's Dedalus raises €72m bond from Tikehau

Deal marks the third direct lending deal executed by Tikehau’s Italy-based team

  • Refinancing
  • 22 December 2016
Gimv sells Multiplicom to Agilent Technologies for €68m
Gimv sells Multiplicom to Agilent Technologies for €68m

GP claims a return on the sale above its long-term average return rate

  • Exits
  • 22 December 2016
626364
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013